MetLife Investment Advisors »

Eledon Pharmaceuticals shares owned by MetLife Investment Advisors

Quarter-by-quarter ownership of Eledon Pharmaceuticals (ELDN) shares owned by MetLife Investment Advisors from 13F filings

Historical chart of MetLife Investment Advisors investment in Eledon Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Eledon Pharmaceuticals held by MetLife Investment Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Eledon Pharmaceuticals by MetLife Investment Advisors

Quarter filed Position value Share count Share price at filing
2026-03-31 $130k 42k 3.08
2025-06-30 $98k 36k 2.71

More positions owned by MetLife Investment Advisors

NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Alphabet Inc Class A Cap Stk Cl (GOOGL)
Broadcom (AVGO)
Alphabet Inc Class C Cap Stk Cl (GOOG)
Meta Platforms Inc Class A Cl A (META)
Tesla Motors (TSLA)
Berkshire Hathaway Inc Class B Cl B New (BRK.B)
Eli Lilly & Co. (LLY)
State Street Spdr S&p Etf Trust Tr Unit (SPY)
JPMorgan Chase & Co. (JPM)
Vanguard Short-term Bond Index Fun Short Trm (BSV)
Exxon Mobil Corporation (XOM)

View all positions for MetLife Investment Advisors

Top funds holding Eledon Pharmaceuticals

BVF
BlackRock
Defilade Capital Management
Vanguard Capital Management
Ensign Peak Advisors
Zimmer Partners
Geode Capital Management
Sphera Funds Management
Catalio Capital Management
Blue Owl Capital Holdings
State Street Corporation
AWM Investment Company
Leucadia National Corporation
Kingdon Capital Management
ADAR1 Capital Management

View all funds holding Eledon Pharmaceuticals